edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: Herantis Pharma
Herantis Pharma is a Finland-based clinical-stage biotechnology company focused on developing disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases.
Herantis Pharma — 2 videos in collection
In this interview, we speak to Antti Vuolanto, CEO of Herantis Pharma. We discuss the company’s recently announced clinical data from its Phase Ib trial in Parkison’s disease patients, what to expect from the upcoming biomarker data and the next steps for Herantis’s lead programme HER-096, a peptide therapeutic.
Listen on your preferred podcast player below:
About Bull, Bear & Beyond: Each episode features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.
Get access to the very latest content matched to your personal investment style.